Eli Lilly LLY announces its next round of earnings this Thursday, July 30. Here is Benzinga's look at Eli Lilly's Q2 earnings report.
Earnings and Revenue
Analysts covering Eli Lilly modeled for quarterly EPS of $1.57 on revenue of $5.77 billion . Eli Lilly EPS in the same period a year ago totaled $1.500. Revenue was $5.64 billion. If the company were to match the consensus estimate when it reports Thursday, earnings would be up 4.67%. Sales would be have grown 4.72% from the same quarter last year. The company's reported EPS has stacked up against analyst estimates in the past like this:
| Quarter | Q1 2020 | Q4 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|
| EPS Estimate | 1.48 | 1.51 | 1.40 | 1.45 |
| EPS Actual | 1.75 | 1.73 | 1.48 | 1.50 |
| Revenue Estimate | 5.51 B | 5.90 B | 5.50 B | 5.59 B |
| Revenue Actual | 5.86 B | 6.11 B | 5.48 B | 5.64 B |
Stock Performance
Over the last 52-week period, shares are up 46.83%. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Don't be surprised to see the stock move on comments made during its conference call. Eli Lilly is scheduled to hold the call at 09:00:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/9cyavje9
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
